X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7755) 7755
Book Review (2045) 2045
Publication (688) 688
Newsletter (646) 646
Newspaper Article (598) 598
Book Chapter (122) 122
Book / eBook (54) 54
Conference Proceeding (24) 24
Trade Publication Article (24) 24
Transcript (16) 16
Dissertation (10) 10
Magazine Article (9) 9
Web Resource (6) 6
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6224) 6224
humans (5903) 5903
lymphomas (4077) 4077
oncology (3115) 3115
hematology (2627) 2627
cancer (2533) 2533
male (2247) 2247
female (2175) 2175
lymphoma (2013) 2013
middle aged (1893) 1893
aged (1721) 1721
adult (1416) 1416
leukemia (1411) 1411
pathology (1371) 1371
research (1362) 1362
mantle cell lymphoma (1308) 1308
genetic aspects (1269) 1269
chronic lymphocytic-leukemia (1196) 1196
prognosis (1080) 1080
b-cell lymphoma (1066) 1066
animals (1041) 1041
care and treatment (1026) 1026
non-hodgkins-lymphoma (1006) 1006
expression (921) 921
apoptosis (912) 912
aged, 80 and over (907) 907
chemotherapy (873) 873
gene expression (864) 864
analysis (863) 863
non-hodgkin's lymphomas (856) 856
hemic and lymphatic diseases (823) 823
immunohistochemistry (806) 806
follicular lymphoma (770) 770
cell line, tumor (769) 769
diagnosis (728) 728
tumors (725) 725
lymphoma, mantle-cell - genetics (699) 699
mutation (697) 697
health aspects (665) 665
rituximab (660) 660
abridged index medicus (639) 639
lymphoma, mantle-cell - pathology (600) 600
proteins (599) 599
translocation, genetic (595) 595
lymphoma, b-cell - genetics (586) 586
survival (580) 580
cell biology (570) 570
medicine & public health (567) 567
mice (549) 549
gene expression regulation, neoplastic (519) 519
antineoplastic agents - therapeutic use (491) 491
treatment outcome (486) 486
patients (480) 480
gene (473) 473
lymphoma, b-cell - pathology (473) 473
flow cytometry (472) 472
immunophenotyping (456) 456
medical research (454) 454
immune system diseases (453) 453
lymphocytes (452) 452
antineoplastic combined chemotherapy protocols - therapeutic use (445) 445
development and progression (444) 444
lymphocytes b (441) 441
genes (440) 440
adolescent (430) 430
immunology (428) 428
disease (426) 426
article (425) 425
classification (416) 416
kinases (414) 414
in situ hybridization, fluorescence (409) 409
t cells (406) 406
drug therapy (404) 404
polymerase chain reaction (402) 402
medicine (401) 401
acute lymphoblastic-leukemia (400) 400
signal transduction (400) 400
risk factors (399) 399
b cells (398) 398
clinical trials (387) 387
immunotherapy (386) 386
multiple-myeloma (379) 379
cyclin d1 (370) 370
lymphoma, non-hodgkin - pathology (368) 368
cancer therapies (364) 364
hematology, oncology and palliative medicine (364) 364
lymphoma, non-hodgkin - genetics (364) 364
cell cycle (362) 362
bone marrow (360) 360
antineoplastic agents - pharmacology (356) 356
multiple myeloma (353) 353
therapy (350) 350
research article (339) 339
lymphoma, large b-cell, diffuse - genetics (334) 334
non-hodgkin lymphoma (333) 333
transplantation (331) 331
lymphoma, mantle-cell - metabolism (330) 330
activation (329) 329
medicine, research & experimental (328) 328
gene expression profiling (323) 323
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (23) 23
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9109) 9109
Chinese (31) 31
German (21) 21
French (19) 19
Japanese (15) 15
Polish (4) 4
Spanish (4) 4
Hungarian (3) 3
Korean (3) 3
Portuguese (3) 3
Russian (2) 2
Croatian (1) 1
Czech (1) 1
Italian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2013, Volume 110, Issue 45, pp. 18250 - 18255
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 19, pp. 2988 - 2996
Journal Article
Blood, ISSN 0006-4971, 03/2012, Volume 119, Issue 9, pp. 1963 - 1971
Journal Article
Cancer Research, ISSN 0008-5472, 02/2010, Volume 70, Issue 4, pp. 1408 - 1418
Journal Article
Blood, ISSN 0006-4971, 10/2017, Volume 130, Issue 17, pp. 1903 - 1910
Journal Article
Journal Article
Blood, ISSN 0006-4971, 04/2010, Volume 115, Issue 13, pp. 2630 - 2639
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2018, Volume 378, Issue 13, pp. 1211 - 1223
Among patients with MCL, many of whom were at high risk, ibrutinib plus venetoclax led to a complete response in 62% at week 16. Among patients with a... 
MEDICINE, GENERAL & INTERNAL | BRUTONS TYROSINE KINASE | WORKING GROUP | PHASE | PROGRESSION-FREE SURVIVAL | RESPONSE ASSESSMENT | CHRONIC LYMPHOCYTIC-LEUKEMIA | NON-HODGKIN-LYMPHOMA | OPEN-LABEL | INHIBITOR | MINIMAL RESIDUAL DISEASE | Lymph Nodes - pathology | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Lymphoma, Mantle-Cell - mortality | Neoplasm, Residual | Bridged Bicyclo Compounds, Heterocyclic - adverse effects | Aged, 80 and over | Female | Historically Controlled Study | Lymphoma, Mantle-Cell - genetics | Pyrazoles - adverse effects | Administration, Oral | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Survival Rate | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Bone Marrow Examination | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Agammaglobulinaemia Tyrosine Kinase | Intention to Treat Analysis | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Aged | Mutation | Sulfonamides - administration & dosage | Protein-Tyrosine Kinases - antagonists & inhibitors | Treatment outcome | Safety and security measures | Drug therapy | Mantle cell lymphoma | Flow cytometry | p53 Protein | Leukemia | Clinical trials | Cancer therapies | Computed tomography | Vomiting | Bone marrow | Medical research | Risk groups | Hematology | Minimal residual disease | Diarrhea | Fatigue | Nausea | Patients | Lymphoma | Bruton's tyrosine kinase | Polymerase chain reaction | Chemotherapy | Lysis | Response rates | Lymphomas | Positron emission tomography | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Blood, ISSN 0006-4971, 02/2013, Volume 121, Issue 8, pp. 1394 - 1402
Journal Article
Blood, ISSN 0006-4971, 2011, Volume 118, Issue 11, pp. 3088 - 3095
Journal Article